BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
(NASDAQ:BIOT) Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not impacted Prop...
How might the adjournment of Proposal No. 1 affect short‑term market sentiment and liquidity for BIOT shares?
What are the potential financial and dilution effects of the pending Acquisition Proposal on current shareholders?
When is BioSig expected to receive final NASDAQ approval and could any delays impact the merger timeline?
12 days ago